US Archives - Page 12 of 188 - European Medical Journal

Elderly patient speaking with a doctor during a medical consultation about memory concerns

Cerebral Lymphatic Therapy Advances Alzheimer’s Disease

Cerebral lymphatic dysfunction is emerging as a promising therapeutic target in Alzheimer’s disease treatment and research.

Oncologist discussing cancer immunotherapy treatment with a patient in a hospital setting

Smart Control of CAR T Cells

Smart control of CAR T cells is advancing cancer immunotherapy by improving precision, safety, and adaptability.

In-hospital ECMO machine displayed

ECMO Mortality Risk Factors Revealed Nationwide

A nationwide cohort study found high in-hospital mortality among adults receiving ECMO, with risk shaped by age and comorbidity

Woman receiving a Botox injection.

Botulinum Toxin Type A Linked to Serum Sickness

Serum sickness after botulinum toxin type A may signal a rare delayed systemic immune reaction. Read more.

Updates in Chronic Hepatitis B Care

A large portion of the session focused on what the guidelines referred to as the “indeterminate phase” or “grey zone” of CHB, a term…

AMJ Microbiology & Infectious Diseases 4 [Supplement 2] 2026

Chronic hepatitis B affects approximately 1.7 million people in the United States and represents a significant public health challenge…

College students discussing meningitis vaccination during an outbreak response

Meningitis Outbreak Highlights Vaccination Importance

A deadly meningitis outbreak in the U.K. has renewed focus on vaccination, early treatment, and outbreak prevention.

Patient lying down while a doctor delivers a clear injection on their abdomen.

Long-Term Secukinumab in Psoriatic Arthritis

Long-term secukinumab treatment preserved bone structure and controlled disease activity in psoriatic arthritis over 48 months.

Breast cancer patient undergoing mammography during clinical imaging assessment

Regional Nodal Irradiation After Breast Response

Regional nodal irradiation in breast cancer showed low recurrence rates after nodal pCR, even when residual breast disease remained.

Midlife woman experiencing migraine symptoms during the menopause transition

What Menopause Transition Means for Migraine

Migraine often becomes more frequent, severe, and harder to manage during the menopause transition in midlife women.